United Therapeutics (UTHR) EBIT Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | -59.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82% |
| Mar 31, 2026 | 4.63% |
| Dec 31, 2025 | 26.65% |
| Sep 30, 2025 | 7.32% |
| Jun 30, 2025 | 21.78% |
| Mar 31, 2025 | 9.95% |
| Dec 31, 2024 | 28.19% |
| Sep 30, 2024 | 14.48% |
| Jun 30, 2024 | 12.92% |
| Mar 31, 2024 | 95.73% |
| Dec 31, 2023 | 58.52% |
| Sep 30, 2023 | 13.93% |
| Jun 30, 2023 | 30.66% |
| Mar 31, 2023 | 19.49% |
| Dec 31, 2022 | 40.36% |
| Sep 30, 2022 | 19.67% |
| Jun 30, 2022 | -3.04% |
| Mar 31, 2022 | 34.61% |
| Dec 31, 2021 | 8.89% |
| Sep 30, 2021 | 15.20% |